Verapamil Hydrochloride NDC 70771-1601

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1601Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1601Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1601-7	70771160107	25 CARTON in 1 CARTON (70771-1601-7) / 5 VIAL in 1 CARTON (70771-1601-5) / 2 mL in 1 VIAL (70771-1601-1)Marketed from Oct 22, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verapamil Hydrochloride
Generic name (nonproprietary): verapamil hydrochloride
Active ingredients: Verapamil hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214215
Marketing start: Oct 22, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 70771-1601_f1081c30-3025-42ce-b222-824630689bb8SPL ID f1081c30-3025-42ce-b222-824630689bb8SPL set ID cccf4a5f-6c5d-4d52-97e4-fe7a2dbd28d8RxCUI 898316, 1665057UNII V3888OEY5R
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470771160107 followed by a unit qualifier and the quantity

Package 70771-1601-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 5, 2022.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214215

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214215
Product	Strength	Form · route	Labeler	Product NDC
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Lifesciences Limited	70771-1602
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1937
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1643
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1644